OptimizeRx to Present at the H.C. Wainwright Virtual BioConnect Conference on January 11, 2021
06 Januar 2021 - 1:31PM
OptimizeRx Corp. (Nasdaq: OPRX), a leading provider
of digital health solutions for life science companies, physicians
and patients, has been invited to present at H.C. Wainwright’s
BioConnect Conference being held virtually on January 11-14, 2021.
The company’s presentation will be available on-demand via the
H.C. Wainwright conference portal here and in the investor
relations section at investors.optimizerx.com beginning at 6:00
a.m. Eastern time on Monday, January 11.
OptimizeRx CEO, William Febbo, will participate in virtual
one-on-one meetings with institutional analysts and investors
throughout the conference.
Management will discuss the company’s expanding addressable
market due to the launch of new digital health solutions, and how
an increasing number of enterprise-level, recurring revenue
engagements are keeping the company on track for another year of
record growth.
OptimizeRx generated $34.3 million in trailing 12-month revenue
ended September 30, 2020, up 44% compared to the same year-ago
period.
Register for the conference here. To schedule a one-on-one
meeting, please contact your H.C. Wainwright representative. For
any questions about OptimizeRx, please contact Ron
Both of CMA at (949) 432-7557 or submit your
request here.
About H.C. WainwrightH.C. Wainwright is a
full‐service investment bank dedicated to providing corporate
finance, strategic advisory and related services to public and
private companies across multiple sectors and
regions. H.C. Wainwright & Co. also provides
research and sales and trading services to institutional
investors. According to Sagient Research Systems, H.C.
Wainwright’s team is ranked as the #1 Placement Agent in terms of
aggregate CMPO (confidentially marketed public offering), RD
(registered direct offering) and PIPE (private investment in public
equity) executed cumulatively since 1998. For more information
about H.C. Wainwright, visit
www.hcwco.com.About OptimizeRx OptimizeRx is
a digital health company that provides communications solutions for
life science companies, physicians and patients. Connecting over
half of healthcare providers in the U.S. and millions of patients
through a proprietary network, the OptimizeRx digital
health platform helps patients afford and stay on medications. The
platform unlocks new patient and physician touchpoints for life
science companies along the patient journey, from point-of-care, to
retail pharmacy, through mobile patient engagement.
For more information, follow the company on Twitter, LinkedIn or
visit www.optimizerx.com.
Important Cautions Regarding Forward Looking
Statements This press release contains
forward-looking statements within the definition of Section 27A of
the Securities Act of 1933, as amended, and such as in section 21E
of the Securities Act of 1934, as amended. These forward-looking
statements should not be used to make an investment decision. The
words 'estimate,' 'possible' and 'seeking' and similar expressions
identify forward-looking statements, which speak only as to the
date the statement was made. The company undertakes no obligation
to publicly update or revise any forward-looking statements,
whether because of new information, future events, or otherwise.
Forward-looking statements are inherently subject to risks and
uncertainties, some of which cannot be predicted, or quantified.
Future events and actual results could differ materially
from those set forth in, contemplated by, or underlying the
forward-looking statements. The risks and uncertainties to which
forward-looking statements are subject include, but are not limited
to, the effect of government regulation, competition and other
material risks.
OptimizeRx Contact Doug Baker,
CFO Tel (248) 651-6568
(x807) dbaker@optimizerx.com Media
Relations Contact Maira Alejandra, Media
Relations Manager Tel (754)
245-7070 malejandra@optimizerx.com Investor
Relations Contact Ron Both, CMA Tel (949)
432-7557 oprx@cma.team
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jul 2023 bis Jul 2024